Halozyme Therapeutics, Inc.
2014 Q2 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/30/2026 | 2,687 | 0.0% | 39,923 | 12/31/2025 |
| 2025 Q3 | 11/7/2025 | 3,245 | 0.0% | 44,243 | 9/30/2025 |
| 2025 Q2 | 7/31/2025 | 2,209 | 0.0% | 42,473 | 6/30/2025 |
| 2024 Q4 | 1/31/2025 | 2,279 | 0.0% | 47,663 | 12/31/2024 |
| 2024 Q3 | 11/4/2024 | 2,711 | 0.0% | 47,361 | 9/30/2024 |
| 2024 Q2 | 8/7/2024 | 2,575 | 0.0% | 49,177 | 6/30/2024 |
| 2024 Q1 | 5/2/2024 | 3,195 | 0.0% | 78,540 | 3/31/2024 |
| 2023 Q4 | 2/2/2024 | 2,903 | 0.0% | 78,540 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 3,000 | 0.0% | 78,540 | 9/30/2023 |
| 2023 Q2 | 8/2/2023 | 2,944 | 0.0% | 81,617 | 6/30/2023 |
| 2023 Q1 | 4/26/2023 | 3,117 | 0.0% | 81,617 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 4,644 | 0.0% | 81,617 | 12/31/2022 |
| 2022 Q3 | 10/28/2022 | 3,227 | 0.0% | 81,617 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 3,591 | 0.0% | 81,617 | 6/30/2022 |
| 2022 Q1 | 5/3/2022 | 3,255 | 0.0% | 81,617 | 3/31/2022 |
| 2021 Q4 | 1/31/2022 | 3,282 | 0.0% | 81,617 | 12/31/2021 |
| 2021 Q3 | 10/27/2021 | 3,423 | 0.0% | 84,140 | 9/30/2021 |
| 2021 Q2 | 7/23/2021 | 3,646 | 0.0% | 80,293 | 6/30/2021 |
| 2021 Q1 | 4/27/2021 | 3,341 | 0.0% | 80,150 | 3/31/2021 |
| 2020 Q4 | 2/3/2021 | 4,106 | 0.0% | 96,138 | 12/31/2020 |
| 2020 Q3 | 10/27/2020 | 2,647 | 0.0% | 100,726 | 9/30/2020 |
| 2020 Q2 | 8/4/2020 | 2,822 | 0.0% | 105,249 | 6/30/2020 |
| 2020 Q1 | 6/19/2020 | 2,237 | 0.0% | 124,360 | 3/31/2020 |
| 2019 Q4 | 1/31/2020 | 2,205 | 0.0% | 124,360 | 12/31/2019 |
| 2014 Q2 | 8/11/2014 | 1,778 | 0.0% | 180,000 | 6/30/2014 |